Table of contents

Clinical and epidemiological research

• Extended report: Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study (18 March, 2014)

  Mark C Genovese, Roy Fleischmann, Daniel Furst, Namieta Janssen, John Carter, Bhaskar Dasgupta, Judy Bryson, Benjamin Duncan, Wei Zhu, Costantino Pitzalis, Patrick Durez, Kosmas Kretsos
• Extended report: Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy (3 April, 2014)

  Josef S Smolen, Michael E Weinblatt, Shihong Sheng, Yanli Zhuang, Benjamin Hsu
• Extended report: Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial (2 December, 2013)

  Tom W J Huizinga, Roy M Fleischmann, Martine Jasson, Allen R Radin, Janet van Adelsberg, Stefano Fiore, Xiaohong Huang, George D Yancopoulos, Neil Stahl, Mark C Genovese
• Extended report: The global burden attributable to low bone mineral density (1 April, 2014)

  L Sànchez-Riera, E Carnahan, T Vos, L Veerman, R Norman, S S Lim, D Hoy, E Smith, N Wilson, J M Nolla, J S Chen, M Macara, N Kamalaraj, Y Li, C Kok, C Santos-Hernández, L March
• Extended report: Adverse outcomes after major surgery in patients with systemic lupus erythematosus: a nationwide population-based study (5 June, 2013)

  Jui-An Lin, Chien-Chang Liao, Yi-Jui Lee, Chih-Hsiung Wu, Wen-Qi Huang, Ta-Liang Chen
• Extended report: The longitudinal relationship between changes in body weight and changes in medial tibial cartilage, and pain among community-based adults with and without meniscal tears (6 June, 2013)

  Andrew J Teichtahl, Anita E Wluka, Yuanyuan Wang, Boyd J Strauss, Joseph Proietto, John B Dixon, Graeme Jones, Andrew Forbes, Susan Kouloyan-Ilic, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Flavia M Cicuttini
• Extended report: Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints (6 June, 2013)

  Daniel Prieto-Alhambra, Andrew Judge, M Kassim Javaid, Cyrus Cooper, Adolfo Diez-Perez, Nigel K Arden
• Extended report: Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial (12 July, 2013)

  Andra Rodica Balanescu, Eugen Feist, Gernot Wolfram, Isabelle Davignon, Michael D Smith, Mark T Brown, Christine R West
• Extended report: Evaluation of the RABBIT Risk Score for serious infections (5 June, 2013)

  A Zink, B Manger, J Kaufmann, C Eisterhues, A Krause, J Listing, A Strangfeld
• Extended report: Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register (7 June, 2013)

  Carlo A Scirè, Mark Lunt, Tarnya Marshall, Deborah P M Symmons, Suzanne M M Verstappen
• Extended report: Does stress affect the joints? Daily stressors, stress vulnerability, immune and HPA axis activity, and short-term disease and symptom fluctuations in rheumatoid arthritis (9 July, 2013)

  Andrea W M Evers, Elisabeth W M Verhoeven, Henriët van Middendorp, Fred C G J Sweep, Floris W Kraaimaat, A Rogier T Donders, Agnes E Eijsbouts, Antoinette I M van Laarhoven, Sabine J M de Brouwer, Lieke Wirken, Timothy R D J Radstake, Piet L C M van Riel
• Concise report: Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study) (19 April, 2014)

  Arthur Kavanaugh, Iain B McInnes, Philip Mease, Gerald G Krueger, Dafna Gladman, Désirée van der Heijde, Yiying Zhou, Jiandong Lu, Jocelyn H Leu, Neil Goldstein, Anna Beutler
• Concise report: What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort (22 May, 2014)

  K Takase, S C Horton, A Ganesha, S Das, A McHugh, P Emery, S Savic, M H Buch